Phase II study of 4-weekly capecitabine monotherapy in advanced/metastatic breast cancer

Verfasser / Beitragende:
[Mikihiro Kusama, Tadashi Nomizu, Kenjiro Aogi, Masataka Yoshimoto, Noboru Horikoshi, Toshio Tabei, Shinzaburo Noguchi, Shigeto Miura, Norio Yoshimura, Morihiko Kimura, Kazushige Toyama, Eisei Shin]
Ort, Verlag, Jahr:
2010
Enthalten in:
Breast Cancer, 17/4(2010-10-01), 233-240
Format:
Artikel (online)
ID: 445188286